Staburo @ conference of the GMDS & CEN-IBS 2020 Dr. Hannes Buchner, Managing Director from Staburo participated in this online Conference on 08 SEP 2020 and talked about the topic “Children and Career” together with Benjamin Hofner from PEI, Cornelia Kunz and...

Staburo supports research on the impact of coronavirus disease on methodological aspects of ongoing clinical trials On behalf of Staburo, Josef Höfler and our former colleague Nicole Krämer submitted comments on the EMA’s draft guidance on “Points to consider on...

Staburo @ Joint EFSPI / BBS Webinar: Estimands addendum is final: Anything new for oncology? We are very proud that Staburo's Managing Director Dr. Hannes Buchner will be a speaker and will talk about "Treatment switching: challenges, estimands, and estimators". All...

  Staburo's 2020 PSI contributions in webinar format on 26 May (15:00 – 17:15 CET) Since the 2020 PSI conference will unfortunately not take place, we decided to share our PSI contributions in an online live webinar with our colleagues. Staburo biostatisticians Nicole...

Staburo supported evaluation of medical device which recently got FDA Emergency Use Authorization for COVID-19Staburo Managing Director Dr. Hannes Buchner and our team was involved in statistical consulting and performing data analysis in a trial for a medical device...

Staburo team stays healthy, positive and at home The Staburo team is entirely working from home, which works quite seamlessly thanks to a well prepared IT infrastructure and software tools. To keep a positive attitude during uncertain times, Staburo Managing Director...

Students from the University of Copenhagen visited StaburoNine Master students from the University of Copenhagen visited Staburo as part of their Statistical Study Trip to Munich.After a welcome from our Managing Director Josef Höfler, the students learned more about...